Literature DB >> 15288380

Replicative homeostasis: a mechanism of viral persistence.

Richard Sallie1.   

Abstract

Acute viral infection is characterised by high-level replication before prompt decline of viraemia and, commonly, viral clearance. This kinetic pattern is generally held to be due to immune control. However, infection with some viruses, notably hepatitis C (HCV), hepatitis B (HBV) and the human immunodeficiency virus (HIV), often results in chronic stable low-level spontaneously fluctuating viraemia, kinetics that are difficult to rationalize on this basis. The persistence of HCV, an RNA virus, is especially problematic and its stability, occurring despite rapid, genomic mutation is highly paradoxical. This paper outlines the hypothesis, and evidence, that viruses autoregulate replication and mutation and describes a mechanism--replicative homeostasis--explaining viral stability. Replicative homeostasis results in stable, but reactive, replicative equilibria that drive quasispecies expansion and immune escape and explain all observed viral behaviours and host responses. This paradigm implies new approaches to antiviral therapy and is broadly relevant to modulation of gene expression. Copyright 2004 Elsevier Ltd.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15288380     DOI: 10.1016/j.mehy.2004.02.050

Source DB:  PubMed          Journal:  Med Hypotheses        ISSN: 0306-9877            Impact factor:   1.538


  4 in total

Review 1.  Replicative homeostasis II: influence of polymerase fidelity on RNA virus quasispecies biology: implications for immune recognition, viral autoimmunity and other "virus receptor" diseases.

Authors:  Richard Sallie
Journal:  Virol J       Date:  2005-08-22       Impact factor: 4.099

2.  The effects of hepatitis C virus core protein on the expression of miR-122 in vitro.

Authors:  Sujuan Li; Xiaokang Xing; Qiao Yang; Hangdi Xu; Jiliang He; Zhi Chen; Haihong Zhu
Journal:  Virol J       Date:  2013-03-27       Impact factor: 4.099

3.  Correlation between pre-treatment quasispecies complexity and treatment outcome in chronic HCV genotype 3a.

Authors:  Isabelle Moreau; John Levis; Orla Crosbie; Elizabeth Kenny-Walsh; Liam J Fanning
Journal:  Virol J       Date:  2008-07-09       Impact factor: 4.099

4.  Antibody-mediated enhancement aggravates chikungunya virus infection and disease severity.

Authors:  Fok-Moon Lum; Thérèse Couderc; Bing-Shao Chia; Ruo-Yan Ong; Zhisheng Her; Angela Chow; Yee-Sin Leo; Yiu-Wing Kam; Laurent Rénia; Marc Lecuit; Lisa F P Ng
Journal:  Sci Rep       Date:  2018-01-30       Impact factor: 4.379

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.